Risk Factors for Increased Hospital Cost for Primary Total Knee Arthroplasty

Matthew Goldner1, Hemant P Reddy1, Michael Biskup1

  • 1Montefiore Medical Center/Albert Einstein College of Medicine, Department of Orthopedic Surgery, Bronx, New York.

Insights

Higher medical comorbidity scores, including obesity (body mass index ≥ 35), diabetes, and heart failure, significantly increase the cost of primary total knee arthroplasty (TKA). Understanding these factors is crucial for managing TKA expenses.

Area of Science:

  • Orthopedic Surgery
  • Health Economics
  • Medical Comorbidity Research

Background:

  • Patients with complex medical comorbidities incur higher costs for primary total knee arthroplasty (TKA).
  • Quantifying the impact of these comorbidities on TKA expenses is essential for cost management.

Purpose of the Study:

  • To evaluate and quantify the influence of medical comorbidities on the overall cost of primary TKA.
  • Identify specific patient factors that independently increase TKA hospitalization expenses.

Main Methods:

  • Retrospective review of 3,077 primary TKA patient billing records (CPT code 27447) from January 2017 to March 2020.
  • Analysis of cost data including anesthesia, operating room, surgeon fees, recovery, room and board, physical therapy, and medical supplies.
  • Gamma regression analyses to identify associations between patient demographics, comorbidities (e.g., BMI, ASA score, CCI), and increased TKA costs.

Main Results:

  • Median TKA cost was $32,129, with medical supplies ($14,966) and room/board ($4,976) as major cost drivers.
  • Independent risk factors for increased cost included BMI ≥ 35, American Society of Anesthesiologists (ASA) scores of 3-4, diabetes, congestive heart failure (CHF), and mild liver disease.
  • Higher Charlson Comorbidity Index (CCI) scores correlated with increased total costs, with median costs rising from $31,545 (CCI 0-5) to $35,099 (CCI ≥ 5).

Conclusions:

  • Elevated BMI (≥ 35), ASA scores (3-4), diabetes, CHF, and mild liver disease are significant independent risk factors for higher costs in primary TKA.
  • The overall cost of primary TKA escalates with increasing patient comorbidity burden, as indicated by CCI scores.
Abstract

Related Concept Videos